English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Meeting Abstract

MR-double-zero: Can a machine discover new MRI contrasts, such as metabolite concentration?

MPS-Authors
/persons/resource/persons238878

Mueller,  S
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons230667

Glang,  F
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons216025

Herz,  K
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84187

Scheffler,  K
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons214560

Zaiss,  M
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mueller, S., Glang, F., Herz, K., Scheffler, K., & Zaiss, M. (2022). MR-double-zero: Can a machine discover new MRI contrasts, such as metabolite concentration? In Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting (ISMRM 2022).


Cite as: https://hdl.handle.net/21.11116/0000-000A-5CB7-1
Abstract
Discovery of MR contrast and/or conventional sequence parameter optimization usually requires a theoretical model to describe MR physics. Here we investigate if novel contrasts can be found by directly running numerical optimization on a real MRI scanner instead of a simulation. To this end, a derivative-free optimization algorithm is set up to repeatedly update and execute a parametrized sequence on the scanner and map the acquired signals to a given target contrast. As proof-of-principle, we show that this enables creatine concentration mapping by learning a CEST-prepared sequence, which is found solely based on known target concentrations in a phantom.